Endothelin-1 activates p38 mitogen-activated protein kinase via endothelin-A receptor in rat myocardial cells
Ueyama, T.; Kawashima, S.; Sakoda, T.; Rikitake, Y.; Ishida, T.; Kawai, M.; Namiki, M.; Yokoyama, M.
Molecular and Cellular Biochemistry 199(1-2): 119-124
1999
ISSN/ISBN: 0300-8177 PMID: 10544960 DOI: 10.1023/a:1006918901356
Accession: 010586398
In myocardial cells (MCs), endothelin-1 (ET-1) exerts various effects such as hypertrophy, and causes cellular injury. Long-term treatment with an endothelin-A (ET(A)) receptor antagonist improves the survival of rats with heart failure, suggesting that myocardial endothelin system contributes to the progression of heart failure. p38 mitogen-activated kinase (MAPK) is a member of the MAPK family and activated by several forms of environmental stresses. We show here the effect of ET-1 on p38 MAPK activation and the role of ET-1-activated p38 MAPK on morphological changes in MCs. ET-1-stimulated p38 MAPK phosphorylation was detectable within 2 min and maximal at 5 min and was concentration dependent. The maximum effect was obtained at 10 nM. An ET(A) receptor antagonist, BQ-123, but not an endothelin-B receptor antagonist, BQ-788, inhibited these reactions. A p38 MAPK inhibitor, SB203580, failed to inhibit the morphological changes associated with ET-1-induced myocardial cell hypertrophy. These results indicate that p38 MAPK is activated by ET-1 but does not contribute to the development of ET-1-induced myocardial cell hypertrophy.